?>
SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Angioscopy and Intravascular Visualization: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara9ba48996

Editorial note
• Last update: 2026-04-27 08:56:36
What is this paper about
Angioscopy emerges as the vascular “direct vision” tool that reveals what angiography often misses: thrombus, plaque rupture, yellow vulnerable plaques, incomplete stent healing, and embolic aortic sources. The full review is worth reading because it maps where this old but powerful technology still has modern clinical value — from coronary risk prediction and DES healing to carotid surgery, bypass quality control, flow-diverter follow-up, and cryptogenic stroke work-up.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Abstract: The aim of this paper is to synthesize the clinical evidence regarding the diagnostic accuracy, interventional utility, and prognostic value of angioscopy across various anatomical substrates, with a particular focus on its comparative performance against traditional imaging modalities and its role in guiding therapeutic decision-making. The review utilises 599 original studies with 32878 total participants (topic deduplicated ΣN). Across the mapped evidence, angioscopy emerges as a highly sensitive modality for direct endoluminal visualization, detecting intracoronary thrombi in up to 61% of cases versus 20% by angiography and identifying aortic plaque rupture with an odds ratio of 14.3 for ischemic stroke. The strongest and most recurrent signals cluster around vulnerable plaque characterization through yellow plaque grading, where patients with five or more yellow plaques showed a 3.8-fold higher event rate and acute coronary syndrome occurred in 28.2% versus 3.4% of yellow versus white plaque carriers. Convergent evidence also supports angioscopy-guided quality control in carotid endarterectomy and infrainguinal bypass, serial monitoring of neointimal or endothelial coverage after carotid stenting, coronary drug-eluting stents, flow diverters, and structural occluder devices, and non-obstructive general angioscopy for aortogenic embolic mechanisms. Clinically, these signals indicate a practical role for angioscopy as a complementary rather than replacement modality, informing selected antiplatelet de-escalation decisions, surgical revision decisions, and risk stratification in cryptogenic stroke and chronic kidney disease. The mapped literature is nevertheless dominated by small, heterogeneous, observational studies with limited inter-observer reproducibility, which tempers certainty around prognostic thresholds and device-specific healing claims. Future research should prioritize adequately powered prospective studies with standardized quantitative colorimetry and validated neointimal or endothelial coverage grading to confirm whether angioscopy-guided decisions improve long-term clinical outcomes across coronary, peripheral, aortic, and neurovascular substrates.

Keywords: Coronary angioscopy; Non-obstructive general angioscopy; Intraoperative angioscopy; Thrombus detection; Aortic plaque rupture; Endovascular therapy; Stent graft positioning; Endothelialization assessment; Endovenous angioscopy; Intravascular visualization

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (226)